Redistribution Center (RDC) AgreementRedistribution Center Agreement • July 28th, 2022 • Dexcom Inc • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledJuly 28th, 2022 Company Industry JurisdictionTHIS REDISTRIBUTION CENTER (RDC) AGREEMENT (“Agreement”), is made effective as of June 6, 2022 (the “Effective Date”), by and between DexCom, Inc. (“Manufacturer”), and U.S. Pharmaceutical, a division of McKesson Corporation (“US Pharma”). Manufacturer and US Pharma may be referred to together as the "Parties" or individually as a "Party.".